Outcomes of a Comprehensive, Pharmacist-Managed Injectable Anticoagulation Discharge Program for the Prophylaxis and Treatment of Venous Thromboembolism

被引:2
|
作者
Reger, Melissa A. [1 ]
Chapman, Jamie L. [2 ]
Lutomski, Dave M. [3 ,4 ]
Mueller, Eric W. [4 ,5 ]
机构
[1] Community Reg Med Ctr, Dept Pharm, Burn Surg, Fresno, CA USA
[2] Blount Mem Hosp, Dept Pharm Serv, Internal Med, Maryville, TN 37804 USA
[3] Univ Cincinnati Hlth, Univ Hosp, Dept Pharm Serv, Surg Trauma, Cincinnati, OH USA
[4] Univ Cincinnati, Clin Pharm, Div Pharm Practice, James L Winkle Coll Pharm, Cincinnati, OH USA
[5] Univ Cincinnati Hlth, Univ Hosp, Dept Pharm Serv, Crit Care, Cincinnati, OH USA
关键词
D O I
10.1177/875512251102700502
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Safe and effective transition of patients receiving injectable anticoagulation, from an inpatient to an outpatient setting, requires patient education, prescription coordination, and appropriate follow-up. Objective: To evaluate a long-standing, hospital-wide, pharmacist-managed injectable anticoagulation discharge program at an urban academic medical center. Methods: This observational study included adults discharged on an injectable anticoagulant between December 1, 2008, and February 28, 2009. The primary endpoint was program adherence, defined as percent of discharged patients whose anticoagulation therapy was coordinated by a pharmacist. Secondary endpoints included duration of patient counseling and medication procurement (including confirmation of current home supply or need for complete procurement of a full/new prescription); length of hospital stay for patients with a primary diagnosis of venous thromboembolism (VTE); and VTE recurrence and bleeding rates at 3 months. Descriptive statistics were used and are presented as proportions and mean (SD). Results: A total of 207 patients discharged on an injectable anticoagulant (3.2 discharges/day) were included. Pharmacist coordination was documented for 180 (87%) patients. Overall, pharmacists spent 37.6 (25.5) minutes per patient, including 19.4 (9.6) minutes for counseling and 19.7 (19.7) minutes for medication procurement; 150 (83%) patients required complete medication procurement lasting 21.4 (19.6) minutes. The length of hospital stay for patients with a primary diagnosis of VTE was 3.2 (2.4) days. At 3 months, 5.3% and 1.4% of assessable patients had recurrent VTE or major bleeding events, respectively. Patients with major bleeding experienced intracranial hemorrhage (n = 2) and gastrointestinal bleeding (n = 1), all beyond the first 2 weeks after discharge. Conclusions: The pharmacist-managed injectable anticoagulation discharge program was completed in a large proportion of patients. Patient education and medication procurement require the majority of time-related resources. Continual process improvement is crucial for hospitals to ensure that all patients discharged with injectable anticoagulation are assessed and receive anticoagulation education.
引用
收藏
页码:199 / 205
页数:7
相关论文
共 48 条
  • [21] Performance outcomes of a pharmacist-managed anticoagulation clinic in the rural, resource-constrained setting of Eldoret, Kenya
    Manji, I.
    Pastakia, S. D.
    Do, A. N.
    Ouma, M. N.
    Schellhase, E.
    Karwa, R.
    Miller, M. L.
    Saina, C.
    Akwanalo, C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (11) : 2215 - 2220
  • [22] Effects of a pharmacist-managed anticoagulation outpatient clinic in Taiwan: evaluation of patient knowledge, satisfaction, and clinical outcomes
    Lin, Shin-Yi
    Chen, Yi-Wen
    Kang, Hao-Cheng
    Wu, Yee-Jen
    Chen, Pin-Zi
    Wu, Chia-Wei
    Lin, Chii-Shan
    Wu, Fe-Lin Lin
    Shen, Li-Jiuan
    Huang, Yen-Ming
    Huang, Chih-Fen
    POSTGRADUATE MEDICINE, 2021, 133 (08) : 964 - 973
  • [23] Health Care Expenditures and Therapeutic Outcomes of a Pharmacist-Managed Anticoagulation Service versus Usual Medical Care
    Hall, Deanne
    Buchanan, Julianne
    Helms, Bethany
    Eberts, Matthew
    Mark, Scott
    Manolis, Chronis
    Peele, Pamela
    Docimo, Anne
    PHARMACOTHERAPY, 2011, 31 (07): : 686 - 694
  • [24] Decreased venous thromboembolism with injectable vs oral anticoagulation after discharge for major orthopedic surgery
    Kwong, Louis M.
    Happe, Laura E.
    Horblyuk, Ruslan
    Farrelly, Eileen
    JOURNAL OF ARTHROPLASTY, 2008, 23 (06): : 25 - 30
  • [25] Hepatitis C treatment outcomes in a pharmacist-managed clinic in a rural tribal health system
    David, Crystal
    David, Dwayne
    Essex, Whitney
    Deming, Paulina
    Qualls, Clifford R.
    Mera, Jorge
    HEPATOLOGY, 2017, 66 : 331A - 331A
  • [26] ANTICOAGULATION FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS AND TREATMENT IN CHILDREN WITH SEVERE TRAUMATIC BRAIN INJURY
    Landisch, Rachel
    Hanson, Sheila
    Punzalan, Rowena
    Braun, Kristin
    Gourlay, David
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (09) : E382 - E382
  • [27] Impact of telephone versus in-person follow-up on patient satisfaction with anticoagulation monitoring in a pharmacist-managed anticoagulation clinic program.
    Rhinard, EE
    Wittkowsky, A
    PHARMACOTHERAPY, 2003, 23 (03): : 425 - 425
  • [29] The first pharmacist-managed anticoagulation clinic under a collaborative practice agreement in Qatar: clinical and patient-oriented outcomes
    Elewa, H. F.
    AbdelSamad, O.
    Elmubark, A. E.
    Al-Taweel, H. M.
    Mohamed, A.
    Kheir, N.
    Mohamed Ibrahim, M. I.
    Awaisu, A.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2016, 41 (04) : 403 - 408
  • [30] Expedited discharge in trauma patients requiring anticoagulation for deep venous thrombosis prophylaxis: The LEAP program
    Bridges, GG
    Lee, MD
    Jenkins, JK
    Stephens, MA
    Croce, MA
    Fabian, TC
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2003, 54 (02): : 232 - 235